Lornoxicam is a painkiller that is part of the group of drugs known as NSAIDs (non-steroidal anti-inflammatory drugs). Ibuprofen not only relieves pain, but also has a fever-reducing and anti-inflammatory effect.
Lornoxicam is prescribed , amongst other things, arthrosis (worn joints), sciatica, rheumatoid arthritis and other inflammations.
Lornoxicam is not registered in the Netherlands Switzerland and France, although it is used in many other countries.
Lornoxicam and the benefit of DNA analysis
The rate at which lornoxicam is processed within your body varies from one individual to another. This means that the efficacy and side effects of lornoxicam can be predicted to some extent on the basis of your genes.
Preventive DNA analysis can therefore be an important tool in optimising your medication.
Lornoxicam and the enzyme CYP2C9
Lornoxicam is processed to a large extent by the enzyme CYP2C9. The activity of this enzyme can vary considerably depending on your genetic predisposition, which means the efficacy of lornoxicam can also differ from person to person, as can the risk of side effects.
Information about your genetic predisposition may therefore provide grounds for extra vigilance in relation to a treatment with lornoxicam.
Read more about CYP2C9 enzyme »
Also known as
Xefo, Chlortenoxicam, Taigalor, Acabel, Bosporon